Washington, DC 1/25/12—Affymetrix announced in an SEC filing that it has agreed to settle a class-action suit brought by Tang Capital Partners, in which Tang alleged Affymetrix had violated the terms of its Senor Convertible Notes (see IBO 12/31/11). As part of the settlement, Affymetrix will commence a tender offer within two weeks to repurchase […]
Washington, DC 12/30/11; New York, NY 12/30/11—Affymetrix disclosed in a regulatory filing that Tang Capital Partners has filed a class action suit in Santa Clara Superior Court against the company in connection with its acquisition of eBioscience (see IBO 11/30/11). Tang Capital Partners is a holder of the company’s 3.50% Senior Convertible Notes Due 2038. […]
San Diego, CA 12/27/11—Illumina has filed suit against Life Technologies alleging patent infringement of US Patent No. 7,060,431 entitled, “Method of Making and Decoding of Arrays Sensors with Microspheres,” by the Ion Personal Genome Machine (PGM) and Ion OneTouch System. Illumina is seeking a permanent injunction and damages. The suit was filed in the US […]
Settlement agreements highlight the second of IBO’s yearly articles on patent infringement litigation involving lab instrument and product companies (see IBO 4/30/11). In addition, new suits involving Agilent, PerkinElmer and Waters were filed. New Litigation Among the patent infringement suits initiated since April is Waters’s complaint against Aurora SFC Systems for infringement of two patents […]
Washington, DC 8/2/11—In a filing with the SEC, Bruker has disclosed that it is investigating anonymous allegations of improper conduct at the Chinese operations of its Bruker Optics subsidiary. The Audit Committee of Bruker’s Board has begun an investigation, assisted with outside counsel and a forensic consulting firm. Bruker stated in the filing: “To date, […]
Familiar names dominate the first of IBO’s twice yearly review of patent litigation among analytical instrument companies. DNA sequencing technology has given rise to a new set of infringement suits. In addition, other life science techniques and XRF are the focus of new litigation. New Suits Affymetrix and Illumina are at it again following the […]
This month, the reauthorization of the America COMPETES Act became law. First passed in 2007, the America COMPETES Act provided funding for science agencies and research (see IBO 8/15/07). Although the new law specifies funding amounts for federal science agencies, it is unlikely that these amounts will be appropriated due to the new Congress that […]
Madison, WI 12/14/10; Santa Clara, CA 12/15/10—Affymetrix announced that the US District Court for the Western District of Wisconsin has granted the Company’s motion for summary judgment that it does not infringe two Illumina patents: US Patent Nos. 7,510,841 (Methods of Making and Using Composite Arrays for the Detection of a Plurality of Target Analytes) […]
A new US food safety bill signed into law this month will increase FDA authority over the US food supply and increase the application of scientific standards to food safety. The Food Safety Modernization Act is the country’s first major food legislation since 1938. The Act is expected to be signed by President Obama early […]
San Jose, CA 11/3/10—In a complaint filed in California Superior Court in Santa Clara County, Affymetrix has charged Pacific Biosciences and 15 former employees with tortious interference with contract, intentional interference with prospective economic advantage, breach of fiduciary duty, breach of duty of loyalty, conspiracy and breach of contract. Affymetrix alleges that since August 2009 […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
